11 Results for "

tautomer

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "tautomer" in MCE Product Catalog:

58
58 Publications Verification
Cat. No.: HY-112921A
CAS No.: 2138299-33-7
Purity:  99.86%
Target:  

STING

Research Areas:  

Inflammation/Immunology

diABZI STING agonist-1 is a tautomerism of diABZI STING agonist-1 tautomerism (HY-112921). diABZI STING agonist-1 is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-112921
CAS No.: 2138498-18-5
Purity:  99.91%
Target:  

STING

Research Areas:  

Inflammation/Immunology

diABZI STING agonist-1 tautomerism is a tautomerism of diABZI STING agonist-1 (HY-112921A). diABZI STING agonist-1 tautomerism is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-100742
CAS No.: 1802977-61-2
Purity:  99.38%
GNE-140 racemate is a racemic mixture of (R)-GNE-140 (HY-100742A) and (S)-GNE-140 (HY-100742B), and also a tautomer of GNE-140 (HY-118241). GNE-140 racemate is an orally active lactate dehydrogenase inhibitor, with an IC50 of 3 nM against human LDHA and an IC50 of 5 nM against LDHB. GNE-140 racemate reduces the phosphorylation level and total protein expression of p38 MAPK, and inhibits EGF-induced AKT phosphorylation. GNE-140 racemate decreases lactate production, regulates glycolysis, the pentose phosphate pathway and nucleotide biosynthesis, increases extracellular pH, inhibits cell proliferation, migration and invasion, and induces caspase-3 activation and ROS accumulation. GNE-140 racemate can be used in research related to breast cancer, cystic fibrosis and pancreatic cancer .
loading...
    loading...
Cat. No.: HY-122620
CAS No.: 2114365-78-3
Purity:  98.33%
Synonyms: Hetrombopag (tautomerism); SHR-8735 (tautomerism)
Rafutrombopag (tautomerism) (Hetrombopag) is an orally active nonpeptide thrombopoietin receptor (TPOR/MPL) agonist. Rafutrombopag can chelate iron and alleviate iron overload while promoting haematopoiesis. Rafutrombopag specifically stimulates proliferation and differentiation of human TPOR‐expressing cells, including 32D‐ MPL and human hematopoietic stem cells through stimulation of STAT, PI3K and ERK signalling pathways. Rafutrombopag effectively up-regulates G1-phase-related proteins, including p-RB, Cyclin D1 and CDK4/6, normalizes progression of the cell cycle, and prevents apoptosis by modulating BCL-XL/BAK expression in 32D-MPL cells. Rafutrombopag protects cardiomyocyte survival from oxidative stress damage as an enhancer of stem cells. Rafutrombopag can be used for the study of immune thrombocytopenia and oxidative stress-related cardiovascular disease .
loading...
    loading...
Cat. No.: HY-W140203
CAS No.: 2963-66-8
Target:  

Fluorescent Dye

Research Areas:  

Others

2-(2′-Hydroxyphenyl) benzimidazole is the most extensively studied excited-state intramolecular proton transfer (ESIPT) molecule, exhibiting normal and tautomer emissions. 2-(2′-Hydroxyphenyl) benzimidazole has been applied as a fluorescent probe in various systems .
loading...
    loading...
Cat. No.: HY-119726A
CAS No.: 1169701-00-1
Synonyms: APX001 (tautomerism); E1211 (tautomerism)
Target:  

Fungal

Research Areas:  

Infection Inflammation/Immunology

Fosmanogepix tautomerism (APX001 tautomerism) is a broad-spectrum and orally active anti-invasive fungal compound. Fosmanogepix tautomerism targets the conserved Gwt1 enzyme required for the localization of glycosylphosphatidylinositol-anchored mannoproteins in fungi, and inhibition prevents proper localization of cell wall mannoproteins, thereby impairing cell wall integrity, biofilm formation, germ tube formation, and fungal growth. Fosmanogepix tautomerism can be used to study invasive fungal infections .
loading...
    loading...
Cat. No.: HY-112921AR
CAS No.: 2138299-33-7
Research Areas:  

Inflammation/Immunology

diABZI STING agonist-1 (Standard) is the analytical standard of diABZI STING agonist-1 (HY-112921A). This product is intended for research and analytical applications. diABZI STING agonist-1 is a tautomerism of diABZI STING agonist-1 tautomerism (HY-112921). diABZI STING agonist-1 is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively .
loading...
    loading...
Cat. No.: HY-188065
CAS No.: 773839-36-4
Target:  

Imidazoline Receptor

Research Areas:  

Cardiovascular Disease

LNP 509 is a selective I1 imidazoline receptor ligand with a bovine pKi value of 6.27. LNP 509 exists mainly in the form of a more stable imine tautomer. Intracisternal administration of LNP 509 in anesthetized rabbits induces a dose-dependent decrease in mean arterial blood pressure. LNP 509 can be used in hypertension-related research .
loading...
    loading...
Cat. No.: HY-N18291
CAS No.: 1426089-45-3
12β-1-O-Tigloyl-1-O-deacetyl-nimbolinin B (Compound 1b) is a nimbolinin-type limonoid found in the fruits of Melia toosendan.12β-1-O-Tigloyl-1-O-deacetyl-nimbolinin B exists as a tautomer of 12α-1-O-tigloyl-1-O-deacetyl-nimbolinin B .
loading...
    loading...
Cat. No.: HY-188067
CAS No.: 497180-72-0
Target:  

Imidazoline Receptor

Research Areas:  

Cardiovascular Disease

LNP-911 is a ligand for the I1 imidazoline receptor. LNP-911 allosterically modulates I1Rs and enhances the effect of agonists on Forskolin (HY-15371)-stimulated cAMP accumulation. LNP-911 exists mainly as a stable imine tautomer. After radioiodination, LNP-911 serves as a selective high-affinity radioligand for characterization studies of I1Rs in membrane preparations. LNP-911 can be used in hypertension-related research .
loading...
    loading...
Cat. No.: HY-100742R
CAS No.: 1802977-61-2
GNE-140 racemate (Standard) is the analytical standard of GNE-140 racemate (HY-100742). This product is intended for research and analytical applications. GNE-140 racemate is a racemic mixture of (R)-GNE-140 (HY-100742A) and (S)-GNE-140 (HY-100742B), and also a tautomer of GNE-140 (HY-118241). GNE-140 racemate is an orally active lactate dehydrogenase inhibitor, with an IC50 of 3 nM against human LDHA and an IC50 of 5 nM against LDHB. GNE-140 racemate reduces the phosphorylation level and total protein expression of p38 MAPK, and inhibits EGF-induced AKT phosphorylation. GNE-140 racemate decreases lactate production, regulates glycolysis, the pentose phosphate pathway and nucleotide biosynthesis, increases extracellular pH, inhibits cell proliferation, migration and invasion, and induces caspase-3 activation and ROS accumulation. GNE-140 racemate can be used in research related to breast cancer, cystic fibrosis and pancreatic cancer .
loading...
    loading...
  • 1